1.Percutaneous coronary intervention vs . medical therapy in patients on dialysis with coronary artery disease in China.
Enmin XIE ; Yaxin WU ; Zixiang YE ; Yong HE ; Hesong ZENG ; Jianfang LUO ; Mulei CHEN ; Wenyue PANG ; Yanmin XU ; Chuanyu GAO ; Xiaogang GUO ; Lin CAI ; Qingwei JI ; Yining YANG ; Di WU ; Yiqiang YUAN ; Jing WAN ; Yuliang MA ; Jun ZHANG ; Zhimin DU ; Qing YANG ; Jinsong CHENG ; Chunhua DING ; Xiang MA ; Chunlin YIN ; Zeyuan FAN ; Qiang TANG ; Yue LI ; Lihua SUN ; Chengzhi LU ; Jufang CHI ; Zhuhua YAO ; Yanxiang GAO ; Changan YU ; Jingyi REN ; Jingang ZHENG
Chinese Medical Journal 2025;138(3):301-310
BACKGROUND:
The available evidence regarding the benefits of percutaneous coronary intervention (PCI) on patients receiving dialysis with coronary artery disease (CAD) is limited and inconsistent. This study aimed to evaluate the association between PCI and clinical outcomes as compared with medical therapy alone in patients undergoing dialysis with CAD in China.
METHODS:
This multicenter, retrospective study was conducted in 30 tertiary medical centers across 12 provinces in China from January 2015 to June 2021 to include patients on dialysis with CAD. The primary outcome was major adverse cardiovascular events (MACE), defined as a composite of cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke. Secondary outcomes included all-cause death, the individual components of MACE, and Bleeding Academic Research Consortium criteria types 2, 3, or 5 bleeding. Multivariable Cox proportional hazard models were used to assess the association between PCI and outcomes. Inverse probability of treatment weighting (IPTW) and propensity score matching (PSM) were performed to account for potential between-group differences.
RESULTS:
Of the 1146 patients on dialysis with significant CAD, 821 (71.6%) underwent PCI. After a median follow-up of 23.0 months, PCI was associated with a 43.0% significantly lower risk for MACE (33.9% [ n = 278] vs . 43.7% [ n = 142]; adjusted hazards ratio 0.57, 95% confidence interval 0.45-0.71), along with a slightly increased risk for bleeding outcomes that did not reach statistical significance (11.1% vs . 8.3%; adjusted hazards ratio 1.31, 95% confidence interval, 0.82-2.11). Furthermore, PCI was associated with a significant reduction in all-cause and cardiovascular mortalities. Subgroup analysis did not modify the association of PCI with patient outcomes. These primary findings were consistent across IPTW, PSM, and competing risk analyses.
CONCLUSION
This study indicated that PCI in patients on dialysis with CAD was significantly associated with lower MACE and mortality when comparing with those with medical therapy alone, albeit with a slightly increased risk for bleeding events that did not reach statistical significance.
Humans
;
Percutaneous Coronary Intervention/methods*
;
Male
;
Female
;
Coronary Artery Disease/drug therapy*
;
Retrospective Studies
;
Renal Dialysis/methods*
;
Middle Aged
;
Aged
;
China
;
Proportional Hazards Models
;
Treatment Outcome
2.Clinical efficacy of off-midline closure techniques for treatment of chronic pilonidal sinus
Chinese Journal of Medical Aesthetics and Cosmetology 2022;28(4):320-322
Objective:To evaluate the clinical efficacy of off-midline closure technique in the treatment of chronic pilonidal sinus.Methods:From July 2014 to July 2018, 59 patients suffered from chronic pilonidal sinus treated by off-midline closure were admitted to the Department of Proctology, Linyi Central Hospital, including 34 males and 25 females. According to the size and scope of the chronic pilonidal sinus, the off-midline flap was designed and sutured.Results:In this group of 59 patients, there were 52 cases of primary healing and 7 cases of incision complications, such as partial incision dehiscence and subcutaneous effusion. After follow-up for 2 years, no recurrence was observed. The scar was not obvious after wound healing. The patient was satisfied with the postoperative appearance.Conclusions:Using the off-midline closure technique to treat chronic pilonidal sinus can deviate from the midline to make the suture tension-free and the gluteal groove elevated. It not only effectively reduce the complication rate in patients, but also has high cure rate, low recurrence rate and does not affect appearance.
3.Curcumin suppresses invasiveness and migration of human glioma cells in vitro by inhibiting HDGF/β-catenin complex.
Qisheng LUO ; Hongcheng LUO ; Huangde FU ; Haineng HUANG ; Huadong HUANG ; Kunxiang LUO ; Chuanyu LI ; Rentong HU ; Chuanhua ZHENG ; Chuanliu LAN ; Qianli TANG
Journal of Southern Medical University 2019;39(8):911-916
OBJECTIVE:
To investigate the effect of curcumin on the invasion and migration of human glioma cells and explore the molecular mechanisms.
METHODS:
MTT assay was used for screening the optimal curcumin concentrations. The effects of curcumin on the invasion and metastasis of human glioma cell lines U251 and LN229 were tested using Transwell assay, Boyden assay and wound-healing assays. The expression of the related proteins and their interactions were determined using Western blotting and coimmunoprecipitation assay.
RESULTS:
Curcumin at the concentration of 20 μmol/L for 48 h was used as the optimal condition for subsequent cell treatment. In the two glioma cell lines, curcumin significantly suppressed the invasion and migration of the cells ( < 0.05) and lowered the expressions of hepatoma-derived growth factor (HDGF), Ncadherin, vimentin, Snail and Slug, but increased the expression of E-cadherin. Interference of HDGF in curcumin-treated glioma cells synergistically inhibited the epithelial-mesenchymal transition (EMT) signals, while overexpression of HDGF significantly reversed the inhibitory effect of curcumin on EMT; curcumin treatment could significantly reduce the binding of HDGF to β-catenin.
CONCLUSIONS
Curcumin suppresses EMT signal by reducing HDGF/β-catenin complex and thereby lowers the migration and invasion abilities of human glioma cells .
Cell Line, Tumor
;
Cell Movement
;
Curcumin
;
Epithelial-Mesenchymal Transition
;
Glioma
;
Humans
;
Intercellular Signaling Peptides and Proteins
;
Neoplasm Invasiveness
;
beta Catenin
4.Clinical research on the efficacy of hyperbaric oxygen combined with Fufanghuangbai liquid on wound healing after perianal abscess surgery
Ruizhong FANG ; Minglei LUO ; Chuanyu MA
Chinese journal of nautical medicine and hyperbaric medicine 2018;25(4):254-256,266
Objective To observe the clinical effects of hyperbaric oxygen (HBO) combined with Fufanghuangbai liquid on wound healing after perianal abscess surgery.Methods One hundred and fifty-eight patients with perianal abscess were randomly divided into the observation group and the control group.The patients of the groups were all treated with conventional surgical treatment and external drug application,but the observation group was supplemented with HBO combined with the spraying of Fufanghuangbai liquid on the wound surface.Clinical effects of the 2 groups were closely observed,and wound healing time,granulation growth,seriousness of pain and edema,as well as wound surface effusion were compared between the 2 groups.Results Wound healing time of the observation group (24.91 ± 5.17) days was significantly shorter than that of the control group (31.23 ± 6.01) days,with statistical significance (P < 0.05).Wound edema and granulation growth on the 7th,14th and 21st days after surgery for the observation group were all superior to those of the control group (P < 0.05).Three days after surgery,there were no significant differences in the seriousness of pain and wound surface effusion,when comparisons were made between the 2 groups (P < 0.05).On the 7th and 14th days after surgery,improvement in the above 2 indicators in the treatment group was significantly better than those of the control group,and statistical significance could be seen,when comparisons were made between the 2 groups(P < 0.05).Conclusion HBO combined with Fufanghuangbai liquid could produce good therapeutic effects on the alleviation of wound edema,relief of pain,reduction of wound surface effusion in the treatment of perianal abscess after surgery,and at the same time,it could shorten hospitalization days and improve patient life quality.For this reason,it was worth further clinical popularization.
5.Clinical research on the efficacy of hyperbaric oxygen combined with Fufanghuangbai liquid on wound healing after perianal abscess surgery
Ruizhong FANG ; Minglei LUO ; Chuanyu MA
Chinese journal of nautical medicine and hyperbaric medicine 2018;25(4):254-256,266
Objective To observe the clinical effects of hyperbaric oxygen (HBO) combined with Fufanghuangbai liquid on wound healing after perianal abscess surgery.Methods One hundred and fifty-eight patients with perianal abscess were randomly divided into the observation group and the control group.The patients of the groups were all treated with conventional surgical treatment and external drug application,but the observation group was supplemented with HBO combined with the spraying of Fufanghuangbai liquid on the wound surface.Clinical effects of the 2 groups were closely observed,and wound healing time,granulation growth,seriousness of pain and edema,as well as wound surface effusion were compared between the 2 groups.Results Wound healing time of the observation group (24.91 ± 5.17) days was significantly shorter than that of the control group (31.23 ± 6.01) days,with statistical significance (P < 0.05).Wound edema and granulation growth on the 7th,14th and 21st days after surgery for the observation group were all superior to those of the control group (P < 0.05).Three days after surgery,there were no significant differences in the seriousness of pain and wound surface effusion,when comparisons were made between the 2 groups (P < 0.05).On the 7th and 14th days after surgery,improvement in the above 2 indicators in the treatment group was significantly better than those of the control group,and statistical significance could be seen,when comparisons were made between the 2 groups(P < 0.05).Conclusion HBO combined with Fufanghuangbai liquid could produce good therapeutic effects on the alleviation of wound edema,relief of pain,reduction of wound surface effusion in the treatment of perianal abscess after surgery,and at the same time,it could shorten hospitalization days and improve patient life quality.For this reason,it was worth further clinical popularization.
6.Lentivirus-mediated shRNA targeting ZNF217 suppresses cell growth, migration, and invasion of glioma cells in vitro.
Qisheng LUO ; Haineng HUANG ; Yuanyang DENG ; Huadong HUANG ; Huangde FU ; Kunxiang LUO ; Chuanyu LI ; Chengjian QIN ; Zhanliang WEI ; XueYu LI
Journal of Southern Medical University 2015;35(7):1024-1033
OBJECTIVETo explore the role of ZNF217 in regulating cell proliferation, migration and invasion in glioma cells.
METHDOSA lentivirus-mediated shRNA-ZNF217 vector was infected into glioma U251 cells, and the interference efficiency was examined by Western blotting. MTT assay, flow cytometry, Transwell assay, and Boyden chamber assay were used to analyze the changes in cell proliferation, migration and invasion. Western blotting was used to detect the changes in ZNF217-related genes in the cells.
RESULTSshRNA-ZNF217 transfection significantly inhibited the expression of ZNF217 in U251 cells and suppressed the cell migration, invasion, growth, and cell cycle transition. ZNF217 knockdown downregulated the expression of pPI3, pAKT, C-Myc, and the mesenchyme biomarker N-cadherin, and stimulated the expression of the epithelium biomarker E-cadherin.
CONCLUSIONZNF217 promotes cell migration, invasion, and growth by activating PI3K/AKT signal to upregulate C-Myc and by modulating the genes associated with epithelial-mesenchymal transition in glioma cells.
Cadherins ; metabolism ; Cell Cycle ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Epithelial-Mesenchymal Transition ; Genetic Vectors ; Glioma ; pathology ; Humans ; Lentivirus ; Neoplasm Invasiveness ; RNA, Messenger ; RNA, Small Interfering ; genetics ; Trans-Activators ; genetics ; Transfection
7.Lentivirus-mediated shRNA targeting ZNF217 suppresses cell growth, migration, and invasion of glioma cells in vitro
Qisheng LUO ; Haineng HUANG ; Yuanyang DENG ; Huadong HUANG ; Huangde FU ; Kunxiang LUO ; Chuanyu LI ; Chengjian QIN ; Zhanliang WEI ; Xueyu LI
Journal of Southern Medical University 2015;(7):1024-1027,1033
Objective To explore the role of ZNF217 in regulating cell proliferation, migration and invasion in glioma cells. Methods A lentivirus-mediated shRNA-ZNF217 vector was infected into glioma U251 cells, and the interference efficiency was examined by Western blotting. MTT assay, flow cytometry, Transwell assay, and Boyden chamber assay were used to analyze the changes in cell proliferation, migration and invasion. Western blotting was used to detect the changes in ZNF217-related genes in the cells. Results shRNA-ZNF217 transfection significantly inhibited the expression of ZNF217 in U251 cells and suppressed the cell migration, invasion, growth, and cell cycle transition. ZNF217 knockdown downregulated the expression of pPI3, pAKT, C-Myc, and the mesenchyme biomarker N-cadherin, and stimulated the expression of the epithelium biomarker E-cadherin. Conclusion ZNF217 promotes cell migration, invasion, and growth by activating PI3K/AKT signal to upregulate C-Myc and by modulating the genes associated with epithelial-mesenchymal transition in glioma cells.
8.Lentivirus-mediated shRNA targeting ZNF217 suppresses cell growth, migration, and invasion of glioma cells in vitro
Qisheng LUO ; Haineng HUANG ; Yuanyang DENG ; Huadong HUANG ; Huangde FU ; Kunxiang LUO ; Chuanyu LI ; Chengjian QIN ; Zhanliang WEI ; Xueyu LI
Journal of Southern Medical University 2015;(7):1024-1027,1033
Objective To explore the role of ZNF217 in regulating cell proliferation, migration and invasion in glioma cells. Methods A lentivirus-mediated shRNA-ZNF217 vector was infected into glioma U251 cells, and the interference efficiency was examined by Western blotting. MTT assay, flow cytometry, Transwell assay, and Boyden chamber assay were used to analyze the changes in cell proliferation, migration and invasion. Western blotting was used to detect the changes in ZNF217-related genes in the cells. Results shRNA-ZNF217 transfection significantly inhibited the expression of ZNF217 in U251 cells and suppressed the cell migration, invasion, growth, and cell cycle transition. ZNF217 knockdown downregulated the expression of pPI3, pAKT, C-Myc, and the mesenchyme biomarker N-cadherin, and stimulated the expression of the epithelium biomarker E-cadherin. Conclusion ZNF217 promotes cell migration, invasion, and growth by activating PI3K/AKT signal to upregulate C-Myc and by modulating the genes associated with epithelial-mesenchymal transition in glioma cells.
9.Effect of β- aescine Sodium on Tumor Necrosis Factor α in Severe Traumatic Brain Injury
Yuanyang DENG ; Haineng HUANG ; Guiyuan WEI ; Huadong HUANG ; Qisheng LUO ; Huangde FU ; Chuanyu LI
Chinese Journal of Rehabilitation Theory and Practice 2014;(3):259-261
Objective To study the effect of β-aescine sodium on tumor necrosis factor α (TNF-α) in patient with severe traumatic brain injury and the clinical significance. Methods 60 patients with severe traumatic brain injury were divided equally into control group (n=30) and treatment group (n=30), who accepted routine therapy and further β-aescine sodium respectively. The serum TNF-α was determined before and 1 d, 2 d, 3 d, 5 d and 7 d after treatment. The patients were assessed with Glasgow Outcome Scale (GOS) 3 months after treatment.Results There was significant difference of serum TNF-α between treatment group and control group since 3 d after treatment (P<0.05). The score of GOS was better in the treatment group than in the control group 3 months after treatment (P<0.05). Conclusion β-aescine sodium is effective on severe traumatic brain injury. Level of TNF-α may be related with the outcome of patients with severe traumatic brain injury.
10.Chemokine 5 and its receptor in breast cancer
Yongyun ZHU ; Yingchun ZHAO ; Chuanyu LUO
Journal of International Oncology 2013;(5):353-355
Chemokine CCL5 and its receptor CCR5,as one of the chemokine family,are involved in the processes of many diseases and especially play an important role in breast cancer.Recent researches show that chemokine CCL5 and its receptor CCR5 have an obvious impact on the tumorigenesis,invasion,metastasis,therapy and prognosis of breast cancer.


Result Analysis
Print
Save
E-mail